Atlas Trials

A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia

Clinical trial NCT02669030 · UNKNOWN

Trial details

NCT number
NCT02669030
Sponsor
Institute for Advanced Medical Research, Alpharetta, GA
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
DepressionMajor Depressive DisorderMDDInsomnia
Start date
2017-03-01
Primary completion
2019-12-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.